Arkansas

Arkansas

Former Arkansas Death-Row Prisoner Rickey Dale Newman Exonerated After Nearly 17 Years in Prison

An Arkansas trial judge has dismissed all charges against former death-row prisoner, Rickey Dale Newman (pictured), setting him free on October 11 after having spent nearly 17 years in custody following the February 2001 murder of a transient woman in a "hobo park" on the outskirts of Van Buren, Arkansas. Newman became the 160th person since 1973 to be exonerated after having having been wrongly convicted and sentenced to death. Newman, a former Marine with major depression, chronic posttraumatic stress disorder from childhood abuse, and an IQ in the intellectually disabled range, was seriously mentally ill and homeless at the time he was charged with murdering Marie Cholette. He was convicted and sentenced to death in June 2002 after a one-day trial in which the court permitted him to represent himself. No physical evidence linked Newman to the murder, but at trial a prosecution expert falsely testified that hair found on Newman's clothing came from the victim. Newman also told the jury he had committed the murder and asked them to impose the death penalty. He subsequently sought to waive his appeals and be executed. The Arkansas Supreme Court initially held that Newman had been mentally competent and granted his request to drop his appeals. However, four days before his scheduled execution on July 26, 2005, Newman permitted federal public defenders, including his current counsel, Julie Brain, to seek a stay of execution. DNA evidence on the blanket on which the victim was found excluded Newman, and the federal defenders obtained DNA testing of the hair evidence that disproved the prosecution's trial testimony. They also discovered that prosecutors had withheld from the defense evidence from the murder scene that contradicted what Newman had described in his confession. A federal court hearing disclosed that the state mental health doctor had made significant errors in administering and scoring tests he had relied upon for his testimony that Newman had been competent to stand trial. The Arkansas Supreme Court subsequently ordered new hearings on Newman's competency and on the evidence the prosecution had withheld from the defense. After those hearings, it wrote that "the record overwhelmingly illustrates that Newman’s cognitive deficits and mental illnesses interfered with his ability to effectively and rationally assist counsel" and overturned Newman's conviction. In September, it issued another ruling barring the use of Newman's incompetent confessions in any retrial. On October 2, Brain submitted a letter to the court saying that “Mr. Newman has now been incarcerated for over 16 years for a murder that he did not commit” and that the Arkansas Supreme Court had found that the invalid statements he had given while mentally incompetent were "the only meaningful evidence against him." In response, special prosecutor Ron Fields submitted letter to the court asking that charges be dismissed. Fields wrote that, without the confessions, prosecutors lacked sufficient evidence to obtain a conviction and "it would be a waste of tax payers money to retry [Newman]."

Mixed Rulings in Arkansas and Arizona Highlight Issue of Lethal-Injection Secrecy

Recent court rulings in Arkansas and Arizona reaching opposite outcomes highlight the continuing controversy over state practices keeping information relating to state acquisition of drugs for use in executing prisoners secret from the public. A state trial court judge in Pulaski County, Arkansas ruled on September 19 that the Arkansas Department of Correction must disclose package inserts from the supplies of the sedative midazolam recently purchased by the state as part of its three-drug execution protocol. On September 21, a federal district court judge in Arizona denied a First Amendment challenge brought by a coalition of news organizations seeking disclosure of who supplies execution drugs to the state. In the Arkansas case, circuit court judge Judge Mackie Pierce rejected arguments by lawyers for the state that the packet inserts were shielded from disclosure under state law because disclosure of the inserts would ultimately result in the discovery of who supplied execution drugs to the state. The Arkansas ruling was the second time a state trial court had ordered the Arkansas Department of Correction to disclose packaging information about its execution drugs under the state's Freedom of Information Act and public-disclosure requirements in the Arkansas Method of Execution Act. In April, another Arkansas judge directed the state to disclose packaging information related to its supply of potassium chloride, the third drug in the execution protocol, which causes the prisoners searing pain before it stops the heart unless the prisoner has been adequately anesthetized. Also in April, the drug distributor, McKesson Medical-Surgical, Inc., sued the state in an attempt to prevent it from carrying out executions with supplies of the paralytic drug, vercuronium bromide, obtained from the company under what McKesson described as false pretenses. Assistant Attorney General Jennifer Merritt had told Judge Pierce that it was necessary to keep the package labels secret because some drug manufacturers had objected to the state’s use of their drugs in executions. In his ruling, Judge Pierce said the Arkansas legislature knew how to grant pharmaceutical companies secrecy under the state's execution law, but didn’t do so. “They know what manufacturers are. They knew what the issues were," he said. The state has appealed the April order and is seeking an emergency stay to block implementation of the current order. In the Arizona case, a group of local and national news organizations, including The Arizona Republic, Guardian News & Media, Arizona Daily Star, The Associated Press, and two local television stations had sought disclosure of the state's drug suppliers, arguing that such disclosure was essential for the integrity of the criminal justice system and to determine whether the death penalty was being carried out humanely. District court judge Grant Murray Snow wrote that while the First Amendment protects speech about the death penalty, it does not require Arizona to disclose "protected information" about the identity of its drug supplier, "to the detriment of the state's ability to carry out its constitutional, lawfully imposed criminal punishments." Last December, Judge Snow had ruled in favor of the media on a separate secrecy issue, requiring the Arizona Department of Corrections to permit media witnesses to see the entire execution, including each time drugs are administered. Media witnesses had been unable to see key portions of the botched execution of Joseph Rudolph Wood in 2014, when he was administered 15 doses of lethal-injection drugs in an execution that took nearly two hours to complete. Arizona has not carried out an execution since then and no executions are currently scheduled.

Arkansas, Nevada Obtain New Supplies of Drugs, Plan to Carry Out Two Questionable Executions

The states of Arkansas and Nevada have announced that they have obtained new supplies of execution drugs that will permit them to carry out two executions in what critics have called questionable circumstances. On August 4, Arkansas obtained a supply of midazolam—the controversial drug used in botched executions in at least four states—paying $250 in cash to an undisclosed supplier for 40 vials of the drug. Then, on August 17, Attorney General Leslie Rutledge asked Governor Asa Hutchinson to set an execution date for Jack Greene (pictured), described by his lawyers as “a severely mentally ill man [with] well-documented brain damage.” Also on August 17, Nevada—which does not currently have an execution protocol in place—announced that it had obtained drugs to execute Scott Dozier, using a three-drug formula that no state has ever tried before. Dozier—who has waived his appeal rights and volunteered to be executed—is scheduled to die on November 14. In a press statement, Greene’s lawyer, John C. Williams, said “[c]apital punishment should not be used on vulnerable people like the severely mentally ill.” Greene, he said, is mentally incompetent and suffers from delusions that “his spinal cord has been removed and his central nervous system has been destroyed.” Responding to this delusion, Williams said, Greene “constantly twist[s] his body and stuff[s] his ear and nose with toilet paper to cope with the pain,” often causing himself to bleed. A spokesperson for Hutchinson—who authorized Arkansas’s unprecedented attempt to execute eight prisoners over an eleven-day span in April—has indicated that the governor will set an execution date for Greene. To execute Dozier, Nevada has indicated that it will use an untried combination of diazepam (Valium), fentanyl (an opiod), and cisatracurium (a paralytic). The state has not yet announced how the drugs will be administered. All but one of the prisoners executed in Nevada since 1977 were found to have waived their appeals; Dozier would be the state's 12th death-row prisoner to volunteer to be executed. Nevada recently spent nearly $900,000 on building a new execution chamber.  

Mid-Year Review: Executions, New Death Sentences Remain Near Historic Lows in First Half of 2017

As we reach the mid-point of the year, executions and new death sentences are on pace to remain near historic lows in 2017, continuing the long-term historic decline in capital punishment across the United States. As of June 30, six states have carried out 13 executions, with 30 other executions that had been scheduled for that period halted by judicial stays or injunctions, gubernatorial reprieves or commutation, or rescheduled. By contrast, at the midpoint of 2016, five states had carried out 14 executions, and 25 other executions had been halted. 12 executions are currently scheduled for the rest of 2017, with 8 others already halted, and several more death warrants are expected to be issued. Depending on whether Ohio carries out the five executions pending between now and December, DPIC anticipates a slight increase in executions in the U.S. from 2016's 26-year low. However, even with the spate of four executions carried out in Arkansas from April 20-27—that state's first executions since 2005—there will likely be fewer executions in 2017 than in any other year since 1990. New death sentences also remain near historically low levels. DPIC has confirmed at least 16 new death sentences so far in 2017, a pace very close to the record-low 31 new death sentences imposed in 2016. Florida's abandonment of non-unanimous jury recommendations of death and Alabama's repeal of judicial override of jury recommendations for life are expected to substantially reduce the number of new death sentences in those states. The death sentences of nearly 100 Florida death-row prisoners have been overturned as a result of the state supreme court's declaration than non-unanimous death sentences are unconstitutional, and courts in Delaware and Connecticut have continued emptying those state's death rows after their death penalty statutes were declared unconstitutional. Three people have been exonerated from death row in 2017—Isaiah McCoy in Delaware, Rodricus Crawford in Louisiana, and Ralph Daniel Wright, Jr. in Florida—bringing the number of death-row exonerations in the U.S. since 1973 to 159. There have also been three grants of clemency in the first half of 2017, bringing the national total since 1976 to 283. President Barack Obama granted clemency to federal death-row prisoner Abelardo Arboleda Ortiz and military death-row prisoner Dwight Loving, and Virginia Governor Terry McAuliffe granted clemency to Ivan Teleguz. All three are now serving sentences of life without parole. The U.S. Supreme Court has issued three significant decisions in 2017 in favor of death-row prisoners. On February 22, in Buck v. Davis, the Court granted relief to Duane Buck due to racially biased testimony on the issue of future dangerousness. A month later, in Moore v. Texas, the Court unanimously struck down Texas' outlier practice for determining intellectual disability in capital cases. In McWilliams v. Dunn, the Court found on June 19 that James McWilliams' constitutional rights were violated when Alabama failed to provide him assistance of an independent mental-health expert. The Court ruled against Texas death-row prisoner Erick Davila on June 26.

Lawyers Call for Investigation of "Horrifying" Arkansas Execution After Witnesses Report "Coughing, Convulsing"

Calling eyewitness accounts "horrifying," attorneys for Arkansas prisoner Kenneth Williams (pictured) are seeking the preservation of evidence and "a full investigation" into what they described as Williams' "problematic execution." Williams' attorney, Shawn Nolan, said the lawyers had "tried over and over again to get the state to comport with their own protocol to avoid torturing our client to death, and yet reports from the execution witnesses indicate that Mr. Williams suffered during this execution." Media witnesses reported that they observed Williams "coughing, convulsing, lurching, jerking, with sound that was audible even with the microphone turned off" during his execution. According to Associated Press reporter Kelly Kissel, "Williams' body jerked 15 times in quick succession — lurching violently against the leather restraint across his chest." Kissel, who has witnessed ten executions, said, "This is the most I've seen an inmate move three or four minutes in." Nolan called the situation "very disturbing, but not at all surprising, given the history of the risky sedative midazolam, which has been used in many botched executions." A spokesperson for Arkansas Governor Asa Hutchinson dismissed the witness accounts, calling the execution "flawless" and Williams' movement an "involuntary muscular reaction." Nolan characterized the spokesperson's statement as "simply trying to whitewash the reality of what happened." Williams was the fourth person executed in Arkansas in eight days. The state had originally planned to execute eight inmates in eleven days, but courts stayed four of the executions for reasons specific to those prisoners. Experts, including former correctional officials, had warned that the rushed execution schedule increased the risk of problematic executions, and attorneys for the prisoners challenged the use of midazolam as the first drug in the three-drug execution protocol, arguing it would not adequately anesthetize the prisoner. Three days before Kenneth Williams' execution, problems were reported in Arkansas' execution of Jack Jones, but a federal judge allowed the state to proceed with the execution of Marcel Williams on the same night.

Arkansas Performs Double Execution Amid Allegations of Botched Lethal Injection

Arkansas carried out the nation's first double execution in nearly 17 years on April 24, 2017. The state executed Jack Jones (pictured, l.) and Marcel Williams (pictured, r.) about three hours apart, with Williams' execution delayed following allegations that Jones' execution may have been botched. Williams' attorneys filed an emergency request for a stay in federal district court, saying that "Mr. Jones's execution appeared to be torturous and inhumane." The state denied the allegations, calling them "utterly baseless." According to Williams' filing, prison staff unsuccessfully tried for 45 minutes to place a central line in Jones' neck, before eventually placing one elsewhere on his body. Witnesses reported that corrections officials did not wait the mandated 5 minutes to perform a consciousness check on Jones, and that he was moving his lips and gulping for air after the sedative midazolam had been administered. U.S. District Judge Kristine Baker issued a temporary stay in response to Williams' request, held a short hearing on the issue, then lifted the stay at approximately 9:30 pm Central time. The double execution was part of an unprecedented schedule of executions set by Arkansas Governor Asa Hutchinson in order to use the state's supply of midazolam, the first of three execution drugs, before it expired. The governor initially set eight executions for an 11-day period, with two executions scheduled for each of four nights. The first two executions, set for April 17, were both stayed indefinitely, one execution was performed and one stayed on April 21. One of the prisoners scheduled for execution on April 27, Jason McGehee, has already received a stay of execution after the Arkansas Parole Board voted 6-1 to recommend that he be granted clemency. Litigation is still pending in the case of Kenneth Williams, the other prisoner scheduled for execution on April 27. [UPDATE: Kenneth Williams was executed on April 27.]

Arkansas Prisoners, Asserting Their Innocence, File Requests for DNA Testing

Two Arkansas death-row prisoners who are scheduled be executed on April 20 have asked the Arkansas courts to stay their executions to permit DNA testing in their cases. Stacey Johnson (pictured, l.) and Ledell Lee (pictured, r.) both say they did not commit the crimes for which they were sentenced to death, and both say that DNA testing methods not available at the time of their trials could prove their innocence. Stacey Johnson was convicted of the 1993 rape and murder of Carol Jean Heath. His conviction rested largely on testimony from the victim's 6-year-old daughter, but records obtained by the defense after the trial indicate that the girl told her therapist that she had not seen anything and was being pressured by her family to identify Johnson. Technology available at the time of Johnson's trial was not sensitive enough to provide DNA results from the sexual assault evidence collected from the victim's body, but newer methods may be able to rule out Johnson and even provide a match to an alternative suspect. At the trial, it was revealed that the victim's boyfriend had abused his former wife for four years, requiring her to obtain emergency custody of her children. It was also revealed that his abuse of his ex-wife included biting her breasts. Significantly, bite marks were identified on the victim’s breasts in Johnson's case. Bryce Benjet of the Innocence Project, which filed Johnson's request, said, "This is not some sort of last-minute, hail mary pass. Johnson asked for DNA testing in earlier appeals, but those requests were denied by State and federal courts. There have been revolutionary advancements in DNA testing since this case was initially investigated which could tell once and for all who actually committed this crime." In a separate filing, Ledell Lee sought new DNA testing of hair and blood evidence, neither of which provided conclusive results using 1995 techniques. Despite a bloody crime scene, no physical evidence directly implicated Lee in the murder. No fingerprint evidence from the scene matched Lee and no DNA evidence was presented to the jury. A state’s expert witness, however, testified at trial that he had found "Negroid head hair" at the scene and the state said there were small spots of blood on Lee's shoes. Lee's lawyers argue that "probative biological evidence currently in the custodian control of the state may now be able to provide—through the use of modern, cutting edge DNA testing technology—confirmation of the veracity of Mr. Lee’s innocence claim." Both defendants' requests have been denied by county judges, and have been appealed to the Arkansas Supreme Court. [UPDATE: The Arkansas Supreme Court issued a stay of execution for Stacey Johnson on the DNA issue, but denied Ledell Lee's motion for a stay. Arkansas executed Lee on April 20.]

State and Federal Courts Grant Stays, Preliminary Injunctions Blocking 8 Arkansas Executions

In legal challenges filed separately by Arkansas death-row prisoners and a company involved in the distribution of pharmaceuticals, the Arkansas state and federal courts issued preliminary injunctions putting on hold the state's plan to carry out an unprecedented eight executions in the span of eleven days. After a four-day evidentiary hearing that ended late in the evening on Thursday, April 13, the United States District Court for the Eastern District of Arkansas issued a preliminary injunction barring Arkansas from carrying out the eight scheduled executions with a three-drug cocktail of midazolam, vecuronium bromide, and potassium chloride. The District Court issued its opinion and order early Saturday, April 15, finding "a significant possibility” that the prisoners' challenge to the lethal injection protocol will succeed and that Arkansas' execution plan denies the prisoners meaningful access to counsel and to the courts during the course of the executions themselves. In granting the preliminary injunction, Judge Kristine G. Baker wrote, "The threat of irreparable harm to the plaintiffs is significant: If midazolam does not adequately anesthetize plaintiffs, or if their executions are ‘botched,’ they will suffer severe pain before they die." The ruling came a week after the U.S. Court of Appeals for the Sixth Circuit upheld a preliminary injunction granted by an Ohio federal district court barring that state from using midazolam in a three-drug execution process. Arkansas has appealed the decision to the U.S. Court of Appeals for the Eighth Circuit.

In another lawsuit filed in state court by McKesson, the company that distributed vecuronium bromide to the Arkansas Department of Corrections, an Arkansas circuit judge issued an order in the late afternoon on Friday, April 14, temporarily blocking the state from using the drug. McKesson had filed a complaint alleging that Arkansas misled them about the intended use of the drug and refused to return it even after being issued a refund. Arkansas appealed the court's order, but after the federal injunction was issued, McKesson asked the Arkansas Supreme Court to vacate the state-court order because it would not be necessary as long as the federal injunction is in place.

Two prisoners separately received individual stays of execution. The Arkansas Supreme Court stayed the execution of Bruce Ward, scheduled for April 17, to allow consideration of his claim that he is incompetent to be executed. A federal district court stayed the execution of Jason McGehee, scheduled for April 27, to comply with the required 30-day public comment period after the Arkansas Parole Board's 6-1 recommendation for clemency.  [UPDATE: The U.S. Court of Appeals for the 8th Circuit reversed the District Court's ruling staying the Arkansas executions based upon its use of midazolam and the U.S. Supreme Court declined to review the issue. The Arkansas Supreme Court lifted the temporary restraining order against the state's use of medicines obtained from the McKessen Corporation to carry out executions.]

Pages